Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study
Anuradha Jayaram, Memuna Rashid, Alison H. M. Reid, Francesco Orlando et autres
The prognosis of newly diagnosed metastatic prostate cancer is highly variable. The primary objective of the PARADIGM prospective cohort study was to evaluate predictors of survival in blood collected at the start of each of the first six treatment cycles from 114 …
gb, it (code pays fourni par la source)
1 citation
Nature Cancer